Normal p53 status and function despite the development of drug resistance in human breast cancer cells

Cell Growth and Differentiation

Volumn 6, Issue 11, 1995, Pages 1395-1403

  Wosikowski, K ^a   Regis, J T ^a   Robey, R W ^a   Alvarez, M ^a   Buters, J T M ^a   Gudas, J M ^a   Bates, S E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PROTEIN P53; VINBLASTINE;

APOPTOSIS; ARTICLE; BREAST CANCER; DNA DAMAGE; DRUG RESISTANCE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL PROCESSING;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN P53; PROTEIN-TYROSINE KINASE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; YEASTS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0028809910     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)